02575.HK
Xuanzhubio-b
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 9.26
+1.82%Price chart
Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18
Key dataSep 18, 2026
OpenHKD 9.20
From 52W high−88.84%
Volume5.45M
Market capHKD 4.17B
P/E (TTM)—
P/S (TTM)74.3x
Div yield—
Key dataSep 18, 2026
Open
HKD 9.20
From 52W high
−88.84%
Volume
5.45M
Market cap
HKD 4.17B
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−17.9x
P/E (TTM)
—
RSI (14)
42.2
MomentumView details →
1D Return
+1.82%
YTD Return
−86.87%
Similar companies
Latest newsMore news →
Xuanzhu Biopharm (02575) announced it is in preliminary discussions with an unidentified party regarding a potential acquisition, with no formal agreement signed as of the announcement date.3d agoHong Kong's Hang Seng Index closed down 109 points, or 0.4%, at 24,604 on September 17, 2026, with the Hang Seng Tech Index falling 14 points to 4,310.3d ago